As a stem-cell-drug-based company aiming at accelerating the biomedical research worldwide, Meribank has built a great team of researchers who can provide professional technical counselling services. We also have completed and state-of-the-art facilities that are able to support a wide range of research for bio/pharmaceutical companies, medical centres, or academic institutions. With our professionals and facilities, We proudly provide outsourcing research services, such as experimental design, drug testing in accordance with the FDA stem cell therapy guideline, as well as biomedical analysis plus information visualization.

Meribank provides mesenchymal stem cell as well as a wide range of research services including trials design, trials implementation, assessment of cell-based drugs, and analysis of biomedical data. Since 2015, Meribank has been operating a stem-cell-drug factory. The factory is entirely constructed and operated based on the international standard PIC/S GMP. We insist in adopting the highest standard facilities and quality assurance system on our patented technique “MSCs scaling up platform” to produce MSC. Each batch of our products must pass multiple assessments to produce qualifying reports, in order to supply with the best quality to our R&D team, and customers domestically and overseas.